Ferritin–drug
conjugates (FDCs) and antibody–drug
conjugates (ADCs) respectively represent the innovative and traditional
mainstream approaches in drug delivery systems, each offering unique
advantages and challenges. This viewpoint delves into the evolving
landscape of drug delivery technologies, specifically focusing on
FDCs and ADCs. Each method exhibits unique advantages and inherent
challenges, shaping their roles in therapeutic applications. The article
provides a comparative analysis of two delivery systems, FDCs and
ADCs, in terms of targeting accuracy, drug loading capacity, and the
nature of the payload itself. This comparison offers valuable insights
into the distinct advantages and disadvantages associated with each
system, enabling a clearer understanding of their potential applications
and limitations in therapeutic contexts. This analysis is crucial
for optimizing the use of these delivery systems across varying medical
contexts, offering a comprehensive overview of their impact on the
field of drug delivery.